All articles by Staff Writer
Staff Writer
Thermo Fisher Scientific Introduces New Reproductive Health Assays to Accelerate Fertility Research
Combined with the Ion Torrent Genexus Integrated Sequencer, new assays deliver valuable genomic insights in the field of aneuploidy analysis
Detection of Enterovirus E-11 by qPCR
On 5 May 2023, France reported an increase in cases of severe neonatal sepsis associated with Enterovirus (Echovirus-11 (E-11)). A total of nine cases of neonatal sepsis with hepatic impairment and multi-organ failure with seven deaths were reported between July 2022 and April 2023 from four hospitals in three regions of France. As of 26 June 2023, different cases have been reported in countries in the European area (1 Croatia, 7 Italy, 2 Spain, 5 Sweden and 2 in UK).
Co-Diagnostics, Inc. Announces Recent Grant Awards
The Company intends to use funds awarded by the Bill & Melinda Gates Foundation toward completion of tuberculosis and HPV tests for its Co-Dx PCR Home™ platform
IDTechEx Discusses Applications of Antimicrobial Technology in Addressing Healthcare Infections
Healthcare-associated infections (HAI), also known as hospital-acquired infections, are a major problem healthcare systems face worldwide. Each year, millions of patients contract infectious diseases while in hospital. These HAIs not only lengthen hospital stays and utilize resources, such as hospital beds, but also have deadly consequences. While proper medical practices, such as good hand hygiene, can go a long way, there are additional tools that health systems can use to address this silent pandemic.
Bruker Enables Advanced Life-Science and Green-Tech Research in the UK
GHz-Class NMR, Structural Biology assisted by Artificial Intelligence, a New Scientific Software Division and Innovative Helium Solutions at EUROMAR 2023
Co-Diagnostics, Inc. Awarded Funding for Co-Dx PCR Home Platform from NIH RADx® Tech Program
The Company intends to use the funds awarded by the National Institutes of Health for completion of its upper respiratory panel multiplex on Co-Dx PCR Home™ platform
Caristo Diagnostics Applauds FDA Approval of Colchicine as First Anti-Inflammatory Drug for Cardiovascular Disease
Colchicine’s Approval Heightens the Need for Technologies Detecting Inflammation Specifically Related to Coronary Arteries
Study Proves iTind Treatment for Enlarged Prostate Lasts More than Four Years
Olympus Corporation, a global medical technology company, announced publication of study data demonstrating that the minimally invasive iTind™ treatment provides long-lasting relief of more than four years for people suffering from the symptoms of an enlarged prostate, also known as BPH.
Gustave Roussy and THERYQ: France welcomes the first FLASH radiotherapy machine to treat patients
Gustave Roussy and THERYQ announce a strategic and structuring partnership to roll out and assess FLASH technology for radiotherapy. French medical technology company THERYQ, specializing in particle accelerators and radiotherapy systems, has provided Gustave Roussy’s Department of Radiotherapy with the first FLASH clinical radiotherapy machine in France for treating superficial tumours.